Related Experiment Video
Updated: Aug 19, 2026

Correlative Light- and Electron Microscopy Using Quantum Dot Nanoparticles
Published on: August 7, 2016
Clinical features of duodenal somatostatinomas
T D O'Brien1, G Chejfec, R A Prinz
1Department of Surgery, Loyola University Medical Center, Maywood, IL 60153.
Background:
Duodenal somatostatinomas are rare tumors that are often asymptomatic or present with local symptoms rather than with evidence of excess somatostatin production. To characterize the clinical presentation and management of these neoplasms we reviewed the course of four patients.
Methods:
The records of three men and one woman with duodenal somatostatinomas, who were treated between 1988 and 1992, are reviewed.
Results:
Three of the patients presented with vague gastrointestinal complaints, and one was free of symptoms. No patient had symptoms of somatostatinoma syndrome, nor did any have associated neurofibromatosis. Three patients were diagnosed after biopsy of a submucosal mass during upper endoscopy. Three patients with tumors that measured less than 2 x 2 cm underwent local resection. One patient with a large tumor and liver metastases underwent a Whipple's operation and resection of the liver lesions. Immunohistochemically all tumors predominantly contained somatostatin, although each had traces of other neuropeptides. All tumors contained psammoma bodies. Follow-up periods ranged from 1 to 4 years.
Conclusions:
Duodenal somatostatinomas often appear with only local symptoms or are completely asymptomatic. Small tumors may be locally excised. Intraarterial methylene blue injection may help localize very small tumors during operation. Larger tumors, including those with localized metastases, should also be resected when possible.
Insights
Duodenal somatostatinomas are rare and often asymptomatic, presenting with local symptoms. Surgical resection is recommended for both small and large tumors, including those with metastases.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Endocrinology
Background:
- Duodenal somatostatinomas are rare neoplasms.
- Often present asymptomatically or with local symptoms, not hormonal excess.
- Characterizing clinical presentation and management is crucial.
Purpose of the Study:
- To characterize the clinical presentation of duodenal somatostatinomas.
- To review the management strategies for these rare tumors.
Main Methods:
- Retrospective review of four patients with duodenal somatostatinomas treated between 1988 and 1992.
- Analysis of clinical presentation, diagnostic methods, and surgical outcomes.
- Immunohistochemical analysis of tumor samples.
Main Results:
- Three patients had vague gastrointestinal complaints; one was asymptomatic.
- No patients exhibited somatostatinoma syndrome or neurofibromatosis.
- Tumors <2 cm underwent local resection; larger tumors with metastases were resected surgically.
Conclusions:
- Duodenal somatostatinomas frequently present with local symptoms or are asymptomatic.
- Local excision is feasible for small tumors.
- Resection is recommended for larger tumors and those with metastases.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Type I Diabetes III: Clinical Manifestations
Pyloric Obstruction
Peptic Ulcer Disease III: Clinical Manifestations and Complications

